During the past decade, UAB Division of Cardiovascular Disease conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UAB Division of Cardiovascular Disease" are "Heart Failure" (1 trials), "Heart Failure Low Output" (1 trials), "High Blood Pressure" (1 trials), "Hypertension" (1 trials) and "PE - Pulmonary Embolism" (1 trials). Many other conditions were trialed in "UAB Division of Cardiovascular Disease" in a lesser frequency.

Most popular intervention types in "UAB Division of Cardiovascular Disease" are "Device" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anticoagulation Agents" (1 trials), "FlowTriever System" (1 trials), "ROX Coupler" (1 trials), "Sham procedure" (1 trials) and "Wearable Cardioverter Defibrillator" (1 trials). Other intervention names were less common.

The vast majority of trials in "UAB Division of Cardiovascular Disease" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UAB Division of Cardiovascular Disease". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in UAB Division of Cardiovascular Disease, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UAB Division of Cardiovascular Disease, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".